chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SIRVA. Intense pain and range of motion problems began around 1 week after getting the flu shot; I don't remember the exact date at this point. Couldn't really hold or carry anything using my left arm. Even putting on my seatbelt or lifting a glass of water hurt, and with anything much heavier than that, like grocery bags, my arm was too weak and hurt too much to hold it. Pain goes from shoulder front down bicep, until elbow. <more below> Since the pain didn't start immediately after getting the shot, for a long time I assumed it couldn't have really been the shot, even though I suspected it might have been, based on where the pain was. Only after reading about SIRVA the other night (never heard of it before; I was Googling "shoulder pain and vaccines") did I realize that that's almost certainly what this is. Since I was seeing my primary doctor for my annual physical yesterday, I discussed this with her. She did a shoulder exam, and is sending me to get a shoulder x-ray. She agrees that what I've been experiencing sounds exactly like SIRVA, and she instructed me to report it using this system.   When my condition didn't get any better after a month - I kept thinking that whatever it was would fix itself with time - I went to a massage therapist/PT for treatment. Condition improved, but there was still a lot of pain moving/using that arm. I had a second treatment this week and I am better yet, but still nowhere near 100%. I have another treatment scheduled in a few weeks. Not sure how many treatments it's going to take to fully recover, but at least I'm seeing progress. At this point, after everything I've read about SIRVA, and after discussing all this with my doctor, it seems clear that this was almost certainly caused by improper administration of the vaccine. I'm no doctor, but I suspect the shot was given too high on my arm. I wasn't paying much attention at the time - I mean, I've had plenty of vaccinations without any problems - but I do remember thinking that where he gave me the shot seemed a little higher than they usually go. But I didn't really think anything of it, because I had no idea that could be a problem. I feel strongly that this should be investigated. I don't know if the person who administered my vaccine made a single mistake - on me - or if he has injured more people and needs retraining. I just know that I have to do my part to make sure he isn't hurting anyone else. This has had a substantial impact on my quality of life for nearly two months now, and it's not over yet. Thank you.
Pt states that shot hurt "way more than normal" on injection. Stated that it was "black and blue and painful for 6 weeks. No swelling. After 6 weeks the pain diminished and he began to lose mobility in the arm. Today he has no pain but now limited range of motion in his shoulder / upper arm."  Pt went to physician for other complaint and mentioned his shoulder issue to provider. Provider could see nothing on exam; ordered x-ray. Nothing remarkable on x-ray. Provider suggested MRI. Pt concerned that numbness / immobility may be permanent or long time recovery.
Had nerve pain that started that night, along with chills.  Two days later had a severe rash around my waist area.  Went to a walk-in clinic and was diagnosed with Shingles.
First felt warm but after 35 minutes of receiving vaccine, she started feeling throat closing up and harder to breathe.  EPI was given at 0907  and rapid response was called and patient was brought immediately to ER.
A report has been received from a Health Professional concerning a 12 month old Female patient, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 11-Feb-2016. Reporter stated that administration to a 12 month old girl FLUMIST was the booster dose received 2 month after the first dose of TIV was given to this healthy girl. The outcome of the event of administration to a child younger than 2 years is unknown. The report was considered to be non-serious. The reporter and company physician considered that there was no causal relationship between administration to a child younger than 2 years and FLUMIST QUADRIVALENT.
Patient developed left-sided facial weakness that has progressed over the past 24 hours. Diagnosed with Bell's palsy.
Tired for about 2 days.  Body aches.  Took some Tylenol and slept.  Lasted 36-48 hours.
tinnitus after getting the Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus after getting the Moderna COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced TINNITUS (tinnitus after getting the Moderna COVID-19 vaccine). At the time of the report, TINNITUS (tinnitus after getting the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
PT developed rash on 2/16/03. Few small red purple itchy used Benadryl. Was seen 2/19/03 As with cheeks pale
Severe headaches after receiving first dose of Moderna vaccine on 04/23/2021. Symptoms first started on 04/24/2021.
Moderna vaccine given 3/23.  Adverse rxn started 3:30 AM diarrhea, dry heaves.  Has gatorade, ondansetron & Tylenol on hand. suggested Pepto bismol with Tylenol only (no ibu with pepto), OR loperamide with Tylenol. Drink clear liq/popsicles to stay hydrated. Reporting to VAERS. Advised to go to ER for fluids if has dark urine, less frequent urination, dizzy, confused
Fever, chills, injection site pain, nausea, and fatigue.  Fever, chills and nausea lasted for 1 hour 20 minutes.  Fatigue the evening before and the following day.
Child's leg broke out with vesicular lesions; MD stated it was chicken pox lesions from vax.
No adverse event; patient who had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient who had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 052D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Nov-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 25-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient who had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient who had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient who had been administered with the Moderna vaccine which were beyond the 30 day beyond use date).    No concomitant medication was reported.  Pharmacist reported that they had more or less 192 patients who had been administered with the Moderna vaccine, which were beyond the 30 day beyond use date.  Beyond use date for lot number 052D22A was reported as 17-Nov-2022.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2023: Upon internal review on 02-Feb-2023, significant corrections performed to update age at vaccination, event onset date, event reported term  and updated narrative. On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated. On 24-Jan-2023: Live Non-significant follow up: Vaccine details updated. On 27-Jan-2023: Follow up received contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master Case
booster; felt achy; had a fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for COVID-19 immunization; Bnt162b2 (Second dose), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; PAIN (non-serious) with onset Nov2021, outcome "recovered" (2021), described as "felt achy"; PYREXIA (non-serious) with onset Nov2021, outcome "recovered" (2021), described as "had a fever".  Additional information: withheld states he with Pfizer Pharmaceuticals Vaccine Customer Service Department and states he has no CEP or program number to provide; states he had a caller on the line who reported that patient had a reaction to the Pfizer Booster vaccine and she described she was having an issue and her doctor recommended her to fast prior to the shot and she took a pill she mentioned for fasting for her booster and after this she experienced events lasted for about 5 days and was asking for information. As per reporter details Transferring agent state he believes the caller spells her name as documented and states he has no further details to provide.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt recvd rubella vax 07MAY88 post partum; one wk following vax inject site became sore, hot & swollen; pain disseminated throughout arm & later other joints of her body; @ time of report arthritis persisted;
Patient began feeling dizzy. Vitals were assessed. BP 130/90, pulse 108, temp 98.5. She then began to feel nauseated and had complained of mild swelling to her throat. Upon examination, no swelling was noted. Lung sounds were clear bilaterally. Vitals were assessed again at 3:00 PM. BP 118/60, pulse 110, temp 98.6. She then began to complain of numbness to her tongue and lips. No swelling was noted. Patient was given water to drink and was able to calm down. After she calmed down, she did state she felt better but still felt dizzy.
Rush, trouble breathing, body week as if air has been sucked out of his body. At night crying for all night, fever, lost of appetite.
Started feeling a little sick on 11/28. Missed one day of work. Still recovering from flu.
This spontaneous report was received from a consumer via call center representative refers to a 62 year old female patient. The patient's medical history include tobacco use (the patient had quit smoking 5 years before reporting data). Concomitant therapies included prednisone (Manufacturer unknown), albuterol sulfate, COMBIVENT and SPIRIVA. On an unknown date in 2011, the patient was vaccinated with PNEUMOVAX 23 (dosing information was not reported) for unknown indication. Approximately on 24-OCT-2011, the patient also received an influenza virus vaccine (unspecified). On 02-NOV-2011, she was hospitalized due to an unknown reason. Patient reported that before the administration of flu shot, she informed that she had cold, but was vaccinated anyway. Outcome of hospitalization was unknown. Causality assessment was not provided.
I got the new vaccine on October 13th and have numbness and tingle on hands and feet.
Sore throat; Pain in injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 02Apr2021 at 11:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The medical history of the patient was reported as none. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:45, the patient experienced sore throat and pain in injection site (vaccination site pain). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was reported as unknown if the patient had received any treatment for the reported adverse events. The clinical outcome of the event sore throat and pain in injection site (vaccination site pain) was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
TODAY HE SUDDENLY DEVELOPED A RASH THAT CONSISTED OF SMALL PINK PAPULES THAT STARTED ON HIS LEGS AND RAPIDLY SPREAD TO THE TRUNK AND FACE.  NO FEVER.  NOT ACTING SICK.  PER DR.
pt recv vax;exp swelling in arm & arm turned hot & hard;gene rash & tx w/ diphenhydramine;f/u info MD stated 2" rash at site of inject;no SOB;w/in 15-20 mins rash resolved & pt recovered;
Both of my legs and my stomach feel hot to the touch off and on; I have flu like symptoms; I have swelling on my left ankle; Felt very tired; I get chills; Injection site left arm is sore / injection site left arm is painful; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful) and FATIGUE (Felt very tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906 and 05E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included PARACETAMOL (ACETAMINOPHEN) for an unknown indication.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful). On 16-Sep-2021, the patient experienced FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), FATIGUE (Felt very tired) and CHILLS (I get chills). At the time of the report, FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful), FATIGUE (Felt very tired) and CHILLS (I get chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-321153.
This spontaneous report as received from a certified Medical Assistant refers to a female patient of unknown age. On an unknown date the patient was in office asking for administration of a third dose of GARDASIL, injection, (lot#, expiration date, dose and route unspecified) approximately one year after 2nd dose was administered. No adverse effect reported. Additional information has been requested.
This spontaneous report was received from a physician via company representative, concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 14-DEC-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot number L024129; expiration date 21-JAN-2017) "10 PK 0.5 ml SD-PFS LLok w tip" (route of administration and anatomical location were not reported). On an unspecified dates, the PNEUMOVAX 23 had one temperature excursion of 24 hours. The lowest recorded temperature was 34 F (1.111111111 celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Shingrix potential administration error/only 2 vials of Powder in it; Shingrix potential administration error/only 2 vials of Powder in it; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix potential administration error/only 2 vials of Powder in it) and inappropriate dose of vaccine administered (Verbatim: Shingrix potential administration error/only 2 vials of Powder in it). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date:12-Jul-2023 The Intern said that they found a box of Shingrix with only two vials of powder in it.  The reporter was looking if they could a two extra diluent for it.  The reporter could be due to administration error not sure. No other information was available. The reporter consented to follow up. The Intern said that they found a box of Shingrix with only two vials of powder in it, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
rash on her neck area; mild tingling in her face; swollen lymph nodes above the collar bone; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash on her neck area), PARAESTHESIA (mild tingling in her face) and LYMPHADENOPATHY (swollen lymph nodes above the collar bone) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced RASH (rash on her neck area), PARAESTHESIA (mild tingling in her face) and LYMPHADENOPATHY (swollen lymph nodes above the collar bone). On 28-Mar-2021, PARAESTHESIA (mild tingling in her face) had resolved. At the time of the report, RASH (rash on her neck area) outcome was unknown and LYMPHADENOPATHY (swollen lymph nodes above the collar bone) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-101615 (Patient Link).   Reporter did not allow further contact
Started this evening itching all over and injection site is sore and itching. Took 50mg of benedryl and not stopped itching. Very painful and uncomfortable.  Arms are mostly hurting from scratching.   Not sure if this is caused from the vaccine
Patient developed swelling in vaccination arm with redness extending from shoulder to elbow. The skin presented as splotchy and red with no raised characteristics and no superior migration. The patient denied swelling or itching of the throat, mouth, or tongue. Given 50 mg of benadryl and observed for an additional 30 minutes (total: 1 hour). With the first dose, pt had slight rash with no itching that subsided in a "few days."
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 012L20A and 010M20A) for COVID-19 vaccination. No medical history reported. On Jan 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 27, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 30, 2021, patient experienced pain in extremity (sore arm). At the time of the report, pain in extremity (sore arm) outcome: unknown. No concomitant medication or treatment information reported.
Intussusception - 1 day intermittent symptoms with colicky abdominal pain, blood tinged mucous stool --> reduced by air enema.  8/28/07 Received pcp medical records which included Hospital D/C summary & H&P.  PCP records included vax records but no lot #s.  T/C to pcp office, stated info on VAERS report correct & will not provide further info on lot #s.  Office visit of 6/14 indicates patient was healthy on day of vax. F/U note of 8/07 indicates patient doing well post op.  D/C Summary indicates paitent experienced mucousy emesis, decreased appetite, abdominal pain, fussy, listless & refusal to lie prone x 1 day & bloody mucously stool on day of admit. Admitted 8/4-8/5/07 for observation s/p IS reduction.  Overnight, IS recurred as evidenced by (+) US.  Then spontaneously resolved. FINAL DX: Intussusception, enema reduced. 9/17/07 Received lab & x-ray reports from hospital.
Information has been received from a 36 year old female patient who in 2006 was vaccinated with the three doses of GARDASIL. The patient was now HPV positive. The consumer stated that she had only one partner in her life and she was vaccinated with GARDASIL before having sexual relations. The patient had not recovered. The patient contacted her physician. Follow up information has been received from the physician, who reported that the patient on 15-NOV-2006 was vaccinated with first dose of GARDASIL (Lot number 653736/0868F), on 26-JAN-2007 with the second dose of GARDASIL (Lot number 653736/0868F). The physician reported that on concomitant vaccines were given. The patient was last seen in the office in 2007, at which time her PAP smear was negative for HPV. Additional information has been requested.
What appear to be COVID arm.  Red rash like area around injection site that is hot and itches.